Does beta-adrenoceptor blocker carvedilol provide cardioprotection via an adenosine-dependent mechanism in ischemic canine hearts?
Carvedilol shows a cardioprotective effect against ischemia and/or reperfusion injury via adenosine-dependent mechanisms.
Flt3L administration in vivo induces lung DCs expansion, favoring myeloid and plasmacytoid DC subsets, which are phenotypically more mature. Flt3L may be useful in the therapy to augment immune function of the lung.